Cargando…

Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers

Papillary renal cell carcinomas (PRCC) are a histologically and genetically heterogeneous group of tumors that represent 15–20% of all kidney neoplasms and may require diverse therapeutic approaches. Alteration of the NF2 tumor suppressor gene, encoding a key regulator of the Hippo signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sourbier, Carole, Liao, Pei-Jyun, Ricketts, Christopher J., Wei, Darmood, Yang, Youfeng, Baranes, Sarah M., Gibbs, Benjamin K., Ohanjanian, Lernik, Spencer Krane, L., Scroggins, Bradley T., Keith Killian, J., Wei, Ming-Hui, Kijima, Toshiki, Meltzer, Paul S., Citrin, Deborah E., Neckers, Len, Vocke, Cathy D., Marston Linehan, W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828210/ https://www.ncbi.nlm.nih.gov/pubmed/29535838 http://dx.doi.org/10.18632/oncotarget.24112

Ejemplares similares

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc
por: Sourbier, Carole, et al.
Publicado: (2019)

Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines
por: Yang, Youfeng, et al.
Publicado: (2021)

Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments
por: Wei, Darmood, et al.
Publicado: (2020)

Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependent
por: Sourbier, Carole, et al.
Publicado: (2015)

Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)
por: Ricketts, Christopher J., et al.
Publicado: (2022)

Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
por: Pahwa, Roma, et al.
Publicado: (2022)

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
por: Lang, Martin, et al.
Publicado: (2023)

Comprehensive characterization of Alu‐mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families
por: Vocke, Cathy D., et al.
Publicado: (2021)

Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
por: Giubellino, Alessio, et al.
Publicado: (2013)

Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion
por: Kauffman, Eric C., et al.
Publicado: (2019)

Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
por: Yang, Youfeng, et al.
Publicado: (2013)

Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors
por: Lang, Martin, et al.
Publicado: (2015)

A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau
por: Ricketts, Christopher J, et al.
Publicado: (2022)

Patient-specific factors influence somatic variation patterns in von Hippel–Lindau disease renal tumours
por: Fei, Suzanne S., et al.
Publicado: (2016)

Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants
por: Prince, Thomas L., et al.
Publicado: (2015)

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)
por: Ricketts, Christopher J., et al.
Publicado: (2015)

Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
por: Sourbier, Carole, et al.
Publicado: (2012)

Correction: A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results
por: Xu, Wanying, et al.
Publicado: (2017)

Mitochondrial Topoisomerase I is Critical for Mitochondrial Integrity and Cellular Energy Metabolism
por: Douarre, Céline, et al.
Publicado: (2012)

Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies
por: Suffredini, Dante A., et al.
Publicado: (2015)

Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project
por: Ricketts, Christopher J., et al.
Publicado: (2014)

Oxygen-independent, CDK4/CDK6-dependent degradation of hypoxia-inducible factor-1α takes cancers’ breath away
por: Neckers, Len
Publicado: (2022)

HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007)

MicroRNA Profiling of Morphologically Heterogeneous Clear Cell Renal Cell Carcinoma
por: Giubellino, Alessio, et al.
Publicado: (2021)

A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated Cells
por: Basseville, Agnes, et al.
Publicado: (2022)

Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
por: Li, Qingdi Quentin, et al.
Publicado: (2017)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors
por: Joshi, Abhinav, et al.
Publicado: (2022)

Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
por: Linehan, W. Marston
Publicado: (2012)

The XIth International Online Symposium on Heat Shock Proteins in Biology and Medicine: Organizers: Stuart K. Calderwood, Elizabeth Repasky & Len Neckers October 27-29, 2021 IN MEMORIAM: Claudina Rodrigues-Pousada (1941–2021)
por: Calderwood, Stuart K., et al.
Publicado: (2022)

Fumarate hydratase-deficient renal cell carcinoma cells respond to asparagine by activation of the unfolded protein response and stimulation of the hexosamine biosynthetic pathway
por: Panarsky, Rony, et al.
Publicado: (2020)

HippoDraw
por: Gravina, M F, et al.
Publicado: (1992)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Calcium, an Emerging Intracellular Messenger for the Hippo Pathway Regulation
por: Wei, Yiju, et al.
Publicado: (2021)

Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity
por: Mollapour, Mehdi, et al.
Publicado: (2011)

Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014)

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
por: Di Malta, Chiara, et al.
Publicado: (2023)

Par-1 Regulates Tissue Growth by Influencing Hippo Phosphorylation Status and Hippo-Salvador Association
por: Huang, Hong-Ling, et al.
Publicado: (2013)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r7doq3245ks6351g4jiui5a4p4